Showing results (31-40 of 209) with videos related to
Sort By:
Pageof 21
Endocrine-Related Cancer|February 7, 2023
Update on the genetics of paragangliomasAnne-Paule Gimenez-Roqueplo, Mercedes Robledo, Patricia L M DahiaEuropean Journal of Endocrinology|October 7, 2010
A novel TMEM127 mutation in a patient with familial bilateral pheochromocytomaNelly Burnichon, Charlotte Lepoutre-Lussey, Julien Laffaire, et al.Human Molecular Genetics|October 1, 2005
Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditionsJean-Jacques Brière, Judith Favier, Paule Bénit, et al.Plos One|November 8, 2019
Evolutionarily conserved susceptibility of the mitochondrial respiratory chain to SDHI pesticides and its consequence on the impact of SDHIs on human cultured cellsPaule Bénit, Agathe Kahn, Dominique Chretien, et al.European Journal of Human Genetics : EJHG|January 8, 2026
Insights from 2057 germline genetic tests in renal cell carcinoma patients support revisiting testing criteriaRoseline Vibert, Yahya El Baroudi, Maude Vecten, et al.Cancer Research|September 23, 2003
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomasAnne-Paule Gimenez-Roqueplo, Judith Favier, Pierre Rustin, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2021
Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1Aurélien Morini, Tom Drossart, Marc-Olivier Timsit, et al.British Journal of Haematology|January 10, 2024
EPAS1-mutated paragangliomas associated with haemoglobin disordersMaxence Mancini, Alexandre Buffet, Baptiste Porte, et al.The Journal of Clinical Endocrinology and Metabolism|April 12, 2012
Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutationsCéline Loriot, Nelly Burnichon, Noémie Gadessaud, et al.Endocrine Pathology|December 21, 2011
Rationale for anti-angiogenic therapy in pheochromocytoma and paragangliomaJudith Favier, Peter Igaz, Nelly Burnichon, et al.Pageof 21